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Abstract
Study Objective: To describe menstrual history, associated dysphoria, and desire for menstrual
management in transgender male and gender diverse adolescents who were assigned female at
birth.
Design: Retrospective chart review.
Setting: Tertiary care children’s hospital.
Participants: All patients seen in a multidisciplinary pediatric gender program from March 2015
through December 2020 who were assigned female at birth, identified as transgender male or
gender non-binary, and had achieved menarche.
Intervention: None.
Main Outcome Measures: Patient demographics, menstrual history, interest in and prior
experiences with menstrual management, parental support and concerns about menstrual
management
Results: Of the 129 included patients, 116 (90%) identified as transgender male and 13 (10%) as
gender non-binary, with an average age of 15 (SD 1.6) years. Almost all (93%) patients reported
menstrually-related dysphoria. The majority (88%) were interested in menstrual suppression. The
most common reasons for desiring suppression were achievement of amenorrhea (97%) and
improvement in menstrually-related dysphoria (63%).
Conclusions: The majority of gender diverse patients assigned female at birth reported
dysphoria associated with menses and desired menstrual suppression. This information can
encourage physicians to raise this topic and offer menstrual management for gender diverse
patients who experience distress related to menses, especially for those who are not ready for or
2

do not desire gender-affirming hormonal treatment. Future research is needed to better
understand patients’ experiences with menses and to determine the optimal menstrual
management methods. This could be an important intervention to improve outcomes for this
vulnerable population.

Key Words: adolescent; transgender; gender non-binary; gender diverse; gender dysphoria;
menses; menstrual management; menstrual suppression; hormonal contraception

Introduction
Transgender and gender diverse youth have an increased incidence of mental health diagnoses,
economic marginalization, social isolation, and physical abuse, all of which are associated with
increased risk of self-harm, alcohol and drug use, and suicidality.1-4 As nomenclature in this field
is constantly evolving, we define the terms that will be used for this manuscript. Gender diverse
individuals are those whose gender identity and expression is different than that typically
associated with the sex they were assigned at birth.1 Transgender males are those who were
assigned female at birth and identify as male. Gender non-binary is an umbrella term for
individuals who do not identify as a binary male or female. They may identify as neither gender,
both male and female at once, or as different genders at different times.5 Gender dysphoria is
distress or discomfort caused by the discrepancy between gender identity and sex assigned at
birth.6
Those who are assigned female at birth and do not identify as female may present to
gynecologists or reproductive healthcare providers for multiple reasons, including preventative
3

care, menstrual issues, contraception, and mental health care, in addition to possible genderaffirming hormone therapy and treatments. Some adolescent or adult transgender male patients
request therapeutic amenorrhea,7,8 but there is little known about this topic, especially in the
pediatric population. While there is known increased dysphoria related to puberty,9 there are
minimal data on dysphoria associated with menses. One study described mixed attitudes towards
menstruation in transmasculine adults,10 and a qualitative study reported distress due to
resumption of bleeding in transgender male adults who stopped gender-affirming hormonal
treatment in order to pursue fertility preservation.11 To our knowledge, there are no published
reports on gender dysphoria, depression, anxiety, or other psychological symptoms or outcomes
related to menses in the adolescent population. In our clinical experience, many transgender and
gender diverse adolescents express significant distress related to menarche and menstruation.
There is an even greater paucity of information about the experiences and treatment goals of
gender non-binary children and adolescents, but there are some data that non-binary youth are at
even higher risk of adverse mental health outcomes than their transgender peers.12,13 The
experience of non-binary individuals who were assigned female at birth and undergo
menstruation is unknown. It can be hypothesized that non-binary persons are as similarly
distressed by menses as transmasculine or transgender males because they also do not identify as
female and thus menses may cause increased gender dysphoria. Conversely, gender non-binary
individuals may be more tolerant of menses because they do not identify as male. However,
while many transgender males desire gender-affirming hormone therapy with testosterone, which
often results in menstrual cessation,14-18 many gender non-binary patients may not desire or use
testosterone.19 Therefore, knowledge about experiences with menstruation and desire for
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menstrual management or suppression in non-binary youth may be even more important to guide
long-term treatment options.
Given that most transgender and gender non-binary youth who are assigned female at birth will
experience menstruation if puberty is not suppressed prior to menarche, their experiences around
menstruation is an important and unexplored topic that may help facilitate conversations about
the adolescents’ well-being and possible treatment options.20 The objective of this study is to
describe the characteristics, menstrual history, associated dysphoria, and desire for menstrual
management in gender diverse adolescents and to assess for any differences in characteristics
between those who identify as transgender males and those who identify as gender non-binary.
These data have the potential to identify gaps in medical treatment and new avenues to improve
care for this vulnerable population.

Materials and Methods
This is a retrospective chart review of all patients who identified as transgender or gender nonbinary and who were seen by at least one provider at the Nemours Children’s Hospital Delaware
multidisciplinary Gender Wellness Program (GWP) between March 1, 2015 through December
17, 2020. GWP is a multidisciplinary program. Patients and their parents or guardians are seen
for a four-session evaluation by a psychologist to assess mental health, family and community
supports, and readiness for medical transition. Patients are then followed by our psychologists
for long-term gender-related care or transitioned to providers in the community. All patients are
encouraged to see an endocrinologist and gynecologist when they are ready for information
about gender-affirming medical treatments, as well as for menstrual management, counseling
about fertility and fertility preservation, and reproductive health. A social worker meets with all
5

patients initially and then as needed to provide support and resources. The GWP team meets
regularly to discuss patients at all stages in the process of exploring gender identity and
treatments. All new GWP patients are 17 years of age or younger. Once patients have established
care, they can be followed by the program through age 20, at which time they are transitioned to
adult care.
Gender diverse patients were identified by electronic medical record queries based on a
combination of encounter types and diagnosis codes and confirmed by chart review. Inclusion
criteria for this study were female sex assigned at birth, transgender male or gender non-binary
gender identity, and achievement of menarche. Included patients were seen by at least one of the
GWP providers during the study time period. Three patients with other gender identities (two
who identified as agender and one as a demi-boy) were excluded due to their very small numbers
and because they did not fit into either of the other more well-defined gender identity subgroups.
Data were abstracted from the electronic medical record (EMR) by three investigators using
standardized Research Electronic Data Capture (REDCap) electronic data capture forms.21 The
investigators met regularly as a team with the primary investigator to ensure consistent data
collection and resolve questions or discrepancies through consensus. Abstracted data included
patient demographics (age, race, ethnicity, insurance, sex assigned at birth, gender identity) and
gender-affirming medical history and treatments. Gender identity was reported by patients as
with no predefined terms or lists. Information about behavioral health symptoms, psychiatric
diagnoses, psychiatric admissions, contacts with a therapist and/or psychiatrist, and use of
psychiatric medication, were collected. Psychiatric diagnoses were made by psychologists or
psychiatrists using Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria.6
Menstrual history (age at menarche, frequency, duration, and flow of menses, menstrual pain and
6

other associated menstrual symptoms, mood symptoms and dysphoria related to menses), sexual
activity, and interest in and prior experiences with menstrual management, including goals for
medication use and parental support and concerns about menstrual management, were also
abstracted. Menstrual symptoms were considered present if reported by the patient, except for
premenstrual dysphoria disorder (PMDD), which has clear diagnostic criteria.6 Information about
sexual activity was also collected. Patients were considered to be sexually active if they engaged
in vaginal or anal intercourse.
Data were entered and managed using a REDCap electronic data capture tool hosted at Nemours
Children’s Hospital.21 Frequency counts and percentages and means and standard deviations
were used to describe data for the entire study sample and by gender subgroup (transgender
male, gender non-binary). Data were compared between the two gender identity subgroups using
two-sample t-tests for continuous variables and chi-square and Fisher exact tests for categorical
variables. A p-value of <0.05 was considered statistically significant. Statistical analyses were
performed using SAS version 9.4.22 This study was approved by the Nemours Children’s Health
System Institutional Review Board.

Results
During the study period, 199 patients were seen by at least one GWP provider. Of these, 129
(65%) met inclusion criteria for this study (Figure 1). Demographic characteristics and sexual
activity history for all patients and by gender identity subgroup are presented in Table 1. Mean
age at initial presentation was 15 years (SD 1.6). Almost all patients were white (90%) and nonHispanic (93%), and the majority (73%) were privately insured.

7

Only 12 (17%) had ever been sexually active, with only 7 patients currently sexually active and
only 5 of these patients engaging in sexual activity that had the biologic potential to result in
pregnancy. An additional 6 patients stated that they were considering becoming sexually active
in the near future, although only 4 of these subjects intended to engage in vaginal intercourse. All
sexually active patients were transgender males. A total of 17 (13%) patients reported a history
of sexual abuse, with no patients experiencing current sexual abuse. Two of these patients also
reported consensual sexual activity.
Very few patients (n=7, 5%) were using gender-affirming hormones (testosterone) at the time of
their first GWP visit. Nearly 90% (n=116) of patients identified as transgender male, and 10%
(n=13) identified as gender non-binary. There was a significant difference in age at initial
presentation between gender identity subgroups, with gender non-binary patients presenting an
average of one year earlier compared to transgender male patients (13.9 vs. 15.1, P = .009).
There were no other differences in demographics between these subgroups.

Menstrual History
The average age of menarche for all study patients was 11.5 years (SD 1.3) (Table 2). The
majority of patients (n=100, 85%) reported regular menstrual cycles. Almost three-quarters of
patients had at least one associated menstrual symptom. The most common symptom was
menstrual pain or cramping (n=76, 66%), with a variety of other symptoms reported by a small
number of patients. Of patients with reported menstrual pain, more than half required use of pain
medication during periods. Almost all patients (n=89, 93%) described increased gender
dysphoria or distress related to menses. There were no significant differences in any menstrual
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characteristics or symptoms between patients identifying as transgender male and those
identifying as gender non-binary.

Menstrual Management
One-quarter (n=29, 24%) of patients reported previous use of a menstrual management method
(MMM), with 19 (15%) currently using an MMM (Table 3). The most common prior method
used was combined oral contraceptive pills (OCPs). Most patients were interested in starting
menstrual management (n=107, 88%). Of those who desired menstrual management, almost all
(n=104, 97%) patients cited a desire for amenorrhea as the reason for use. In addition, 63%
(n=67) of patients stated that reduction in menstrually-related dysphoria was a motivating reason.
Only 5 (4%) patients stated that they desired contraception. All of these patients were currently
sexually active. In fact, 66 (50%) subjects explicitly stated that their desire for hormonal
medication was not for contraception.

Parental Support
Of the 51 patients for whom data were available from the EMR about parental support for
menstrual management, almost three-quarters (n=37) of parents were supportive of menstrual
management (Figure 2). Only 6 (12%) parents were explicitly not supportive of initiation of
MMM, with the remaining 8 (16%) reporting uncertainty or mixed feelings. There were no
differences in parental support by gender identity subgroup. Regardless of whether parents
voiced support for menstrual management, there were many reported parental concerns about its
use. The most common concerns were side effects and long-term effects (Figure 3).
9

Discussion
This study describes transgender and gender diverse adolescents’ experiences with menses. This
is an issue that is anecdotally distressing to transgender and non-binary patients who were
assigned female at birth and do not identify as female. However, to our knowledge, there are no
prior published data on this subject. Many adolescents may desire gender-affirming hormone
treatment with testosterone in part to stop menses, but testosterone use may not be appropriate
for some patients due to age, parental reluctance, or lack of desire for testosterone.
Our data provide the first evidence that transgender and gender non-binary adolescents are
distressed by their periods. Their menstrual history and associated pain and other symptoms are
consistent with that of the general adolescent population.23-25 However, our patients report high
rates of mood symptoms related to menses and significant gender dysphoria or distress that is
caused or exacerbated by their periods. There is a strong desire for menstrual suppression in this
population, with a primary goal of achieving amenorrhea. Desire for amenorrhea is different than
menstrual goals for the general adolescent population, in which menstrual regulation or
improvement is the typical request.26 This is especially important information because many
patients are started on combined OCPs for menstrual suppression and this method has lower rates
of amenorrhea than other options.27 In addition, given our population’s low rates of sexual
activity and lack of interest in contraception, methods that have a high likelihood of resulting in
amenorrhea may be more desirable to patients than traditional methods that are known to be used
for contraception. The information from this study can help providers consider other menstrual
management options, although more information is needed to determine the optimal menstrual
management methods in this population.
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We present data separately for transgender males and gender non-binary patients because we
suspect that they are similar but different populations, especially in respect to experiences with
menstruation. Although no differences were seen between these subgroups, the small number of
patients who identified as non-binary may have obscured any potential differences. There was a
significant age difference, with the non-binary group presenting an average of 1 year younger
than the transgender group. This may be of no clinical significance, but it also may be due to
youth feeling more comfortable coming out as non-binary at an earlier age. Importantly, all the
non-binary patients in our study population reported worsened gender dysphoria associated with
menses. More research is needed on this subgroup of gender diverse patients, which may
especially benefit from qualitative, patient-reported data on this topic.
Given the age of this population, parental knowledge, support, and consent may be major factors
in decisions about and initiation of treatment. Our patients’ parents were generally supportive of
menstrual management or suppression, although they reported some concerns, especially about
potential side effects. This is likely higher than the support for use of gender-affirming
hormones, especially for younger patients, although there are no data on this topic. Possible
reasons for the high acceptability of menstrual management are that many of these methods are
familiar to parents for other reasons and are also completely reversible. Further research is
needed to explore this topic.
Strengths of this study are the relatively large sample size and the breadth of information
available from patients seen at a multidisciplinary gender program. The main limitation of this
study is its retrospective nature, which relies on adequate documentation of variables sometimes
difficult to extract, and the resultant missing data. While provider EMR templates were used to
gather some of this information, there were not standardized questionnaires or tools. For those
11

patients seen by a gynecologist in the GWP, there was likely more data available about menstrual
history and menstrual management than those who were not seen by this specialty. Another
limitation is the smaller number of patients for whom information was available in the electronic
medical record about parental support and concerns related to menstrual suppression. This is new
information that deserves further study. As almost all patients reported significant distress or
increased gender dysphoria related to menses, this precluded any analyses of the effects of this
factor on overall mental health. Lastly, this study may have limited generalizability. The fact that
these patients were all seen in a specialized gender care clinic introduces a selection bias and
may overestimate the degree of both gender dysphoria in general and distress related to menses.
In addition, the patients who opted to see a pediatric gynecologist may be more distressed by
menses and interested in menstrual management, although patients who did not see Gynecology
were also included in this study. Our patient population also has limited racial and ethnic
diversity. The majority of patients were white, non-Hispanic, and privately insured. As there is
no known national demographic information for adolescents who identify as transgender or
gender diverse, it is difficult to know whether this information is generalizable to a broader
population. However, the demographic composition of our population is significantly different
than that of children and adolescents in the surrounding county and state, with a higher
proportion of White (90% for our subjects vs. 49% in the county and 52% in the state) and nonHispanic (93% vs. 86% for both the county and state) individuals in our population compared to
these surrounding areas.28 The ways that our population differs from the local community and
the reasons for these differences deserve further study.
This study provides new information about a significantly understudied area for the transgender
population. These data highlight the importance of providers raising these topics and offering
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menstrual management for gender diverse patients who experience distress related to menses,
especially for those who are too young, not currently ready for, or do not desire gender-affirming
hormonal treatment. Future research is needed to obtain more information about patients’
experiences with menses and menstrual management, as well as to determine the optimal
menstrual management methods for this population to induce amenorrhea, improve menstruallyrelated moods, and help relieve gender dysphoria. This could be an important intervention to
improve the mental health and overall health outcomes for individuals in this vulnerable
population.
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Figure Legends
Figure 1. Flow chart of patients in the final analysis sample
Figure 2. Parental support of menstrual suppression
Figure 3. Parental concerns about menstrual suppression, even if supportive of it
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